Ortivus

October-December 2025

• Net sales decreased by 12% and amounted to SEK 18.8 (21.3) million.
• The gross margin increased to 41 (21)%.
• EBITDA amounted to SEK -3.9 (-4.4) million.
• Adjusted EBITDA* amounted to SEK -1.6 (2.3) million.
• Net profit after tax amounted to SEK -7.0 (-9.6) million.
• Earnings per share before and after dilution amounted to SEK -0.10 (-0.22).

 
January-December 2025

• Net sales decreased by 9% and amounted to SEK 73.4 (80.4) million.
• The gross margin amounted to 40 (35)%.
• EBITDA amounted to SEK -15.9 (-13.8) million.
• Adjusted EBITDA* amounted to SEK -8.6 (-4.9) million.
• Net profit after tax amounted to SEK -21.9 (-24.9) million.
• Earnings per share before and after dilution amounted to SEK -0.43 (-0.56).

 
Significant events during and after fourth quarter

• The directed rights issue, which was registered on 3 November and fully subscribed, raised SEK 52 million for the Company after transaction costs.
• Items of a non-recurring nature impacted the quarterly result by SEK 2.2 million. For the full year, non-recurring items amounted to SEK 7.4 million.
• On 13 January, it was announced that Ponderus Invest AB holds 80 per cent of the Company following the mandatory cash offer made in accordance with the Takeover Code.
• In February, Minni Raij joined the Company as Chief Financial Officer.
• The Board of Directors proposes that no dividend be paid for the financial year 2025.